Shree Ram Proteins Limited (NSE: SRPL) announced two significant regulatory filings on August 17, 2026, submitting its audited standalone financial results for the quarter and full year ended March 31, 2026, alongside its unaudited standalone results for the quarter ended June 30, 2026, accompanied by a limited review report. Both outcomes were communicated to the National Stock Exchange following a Board Meeting held the same day.

Filing Details

The company filed its audited results for the financial year ended March 31, 2026, marking the conclusion of FY26 reporting obligations. Simultaneously, SRPL submitted its Q1 FY27 results covering the three-month period ended June 30, 2026. The Q1 FY27 submission was accompanied by a limited review report from the company's statutory auditors, fulfilling SEBI's listing obligations and disclosure requirements under the LODR Regulations.

Market and Trading Data Unavailability

As of the time of this filing, live quote data, trade information, and delivery percentage figures for SRPL were not available through exchange data feeds. Investors seeking current price levels, 52-week high and low ranges, and delivery-based trading volumes are advised to refer directly to the NSE market data portal for the most recent session figures. The absence of real-time trade data limits any assessment of market reaction to these dual filings at this time.

Dividend History Context

SRPL's disclosed dividend history on record contains no prior dividend announcements. The company has not declared any interim or final dividend in the periods covered by available historical data. Neither the FY26 annual results filing nor the Q1 FY27 submission included any dividend recommendation or declaration by the Board, meaning no shareholder payout event is associated with these announcements.

Company Background

Shree Ram Proteins Limited is listed on the NSE under the symbol SRPL with ISIN INE008Z01012. The company operates in the proteins segment, which broadly falls within the agro-processing and food ingredients space in India. As a listed entity, SRPL is bound by SEBI's quarterly and annual reporting timelines, and both filings on August 17, 2026, appear to be in adherence with those regulatory deadlines.

What This Means for Investors

The simultaneous release of FY26 audited financials and Q1 FY27 results provides investors with back-to-back data points to assess the company's year-end performance as well as its early trajectory in the current financial year. The presence of a limited review report for Q1 FY27 confirms auditor oversight of interim numbers, which is a standard compliance requirement under SEBI norms. Investors should review the actual financial statements, including revenue, EBITDA, and net profit figures, once they are available through the NSE filing portal. Without PE ratio, sector PE benchmarks, or price data, a valuation context cannot be established at this stage. Shareholders are encouraged to examine the detailed financial schedules accompanying both filings for a complete picture of the company's financial health.